CORBUS PHARMACEUTICALS HLDGS's ticker is and the CUSIP is 21833P903. A total of 1 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $12 | -99.9% | 116,100 | -2.0% | 0.00% | – |
Q3 2022 | $19,000 | -40.6% | 118,500 | -7.2% | 0.00% | – |
Q2 2022 | $32,000 | -54.9% | 127,700 | -4.5% | 0.00% | – |
Q1 2022 | $71,000 | +39.2% | 133,700 | +60.9% | 0.00% | – |
Q4 2021 | $51,000 | -52.8% | 83,100 | +39.2% | 0.00% | – |
Q3 2021 | $108,000 | 0.0% | 59,700 | +0.5% | 0.00% | – |
Q2 2021 | $108,000 | -52.6% | 59,400 | +5016.3% | 0.00% | – |
Q1 2021 | $228,000 | +123.5% | 1,161 | +41.4% | 0.00% | – |
Q4 2020 | $102,000 | -77.8% | 821 | -67.9% | 0.00% | -100.0% |
Q3 2020 | $460,000 | -10.3% | 2,559 | +318.1% | 0.00% | 0.0% |
Q2 2020 | $513,000 | -3.8% | 612 | -39.9% | 0.00% | 0.0% |
Q1 2020 | $533,000 | +119.3% | 1,018 | +128.3% | 0.00% | 0.0% |
Q4 2019 | $243,000 | +800.0% | 446 | +682.5% | 0.00% | – |
Q3 2019 | $27,000 | -54.2% | 57 | -33.7% | 0.00% | – |
Q2 2019 | $59,000 | -25.3% | 86 | -25.2% | 0.00% | – |
Q1 2019 | $79,000 | +172.4% | 115 | +130.0% | 0.00% | – |
Q4 2018 | $29,000 | – | 50 | +4900.0% | 0.00% | – |
Q3 2018 | $0 | -100.0% | 1 | -95.8% | 0.00% | – |
Q2 2018 | $12,000 | +1100.0% | 24 | -75.8% | 0.00% | – |
Q1 2018 | $1,000 | -90.0% | 99 | -40.0% | 0.00% | – |
Q3 2017 | $10,000 | +900.0% | 165 | -38.0% | 0.00% | – |
Q2 2017 | $1,000 | -94.7% | 266 | -52.1% | 0.00% | -100.0% |
Q1 2017 | $19,000 | -40.6% | 555 | +96.1% | 0.00% | -50.0% |
Q4 2016 | $32,000 | – | 283 | +28200.0% | 0.00% | – |
Q3 2016 | $0 | – | 1 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 323,800 | $405,000 | 0.00% |
SIMPLEX TRADING, LLC | 821 | $102,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |